Edition:
United States

Lexicon Pharmaceuticals Inc (LXRX.OQ)

LXRX.OQ on NASDAQ Stock Exchange Global Select Market

5.01USD
3:59pm EST
Change (% chg)

$-0.74 (-12.87%)
Prev Close
$5.75
Open
$5.79
Day's High
$5.79
Day's Low
$4.99
Volume
345,520
Avg. Vol
187,901
52-wk High
$13.97
52-wk Low
$4.99

Select another date:

Thu, Jan 17 2019

FDA advisory panel split over Sanofi-Lexicon diabetes drug

An advisory panel to the U.S. Food and Drug Administration was divided over whether to recommend approval of a treatment for type 1 diabetes developed by Lexicon Pharmaceuticals Inc and France's Sanofi SA.

UPDATE 2-FDA advisory panel split over Sanofi-Lexicon diabetes drug

Jan 17 An advisory panel to the U.S. Food and Drug Administration was divided over whether to recommend approval of a treatment for type 1 diabetes developed by Lexicon Pharmaceuticals Inc and France's Sanofi SA.

FDA advisory panel split over Sanofi-Lexicon diabetes drug

Jan 17 Independent experts on an FDA advisory panel were equally split when voting on whether to approve an oral treatment for type 1 diabetes developed by Lexicon Pharmaceuticals Inc and France's Sanofi SA.

Select another date: